Tenofovir Disoproxil Fumarate is a medication used to treat chronic hepatitis B and to prevent and treat HIV/AIDS.

The announcement was made during market hours today.

Shilpa Medicare is a global brand in manufacturing and supplying of affordable API and formulation globally in different regulated markets.

On a consolidated basis, Shilpa Medicare's net profit slumped 77.35% to Rs 7.83 crore on 5.44% decrease in revenue from operations to Rs 208.03 crore in Q4 March 2021 over Q4 March 2020.

Powered by Capital Market - Live News

The Board of Shilpa Medicare at its meeting held on 12 July 2021 has approved the transfer of API Business of the Company consisting of Unit-1 and Unit-2 situated at Raichur, Karnataka by way of slump sale to a wholly Owned Subsidiary of the Company (to be incorporated) subject to the approval of Shareholders.

Powered by Capital Market - Live News

2DG has been given emergency approval by the Drug Controller General of India (DCGI) for COVID-19 patients in the country. Shilpa Medicare Limited is only the second company in India to have entered into similar arrangement with DRDO.

Shilpa has been continuously striving to contribute towards the fight against COVID-19 and this is yet another step by the company after its recently announced arrangement for manufacture and supply of Sputnik V vaccine.

Shilpa Medicare is a global brand in manufacturing and supplying of affordable API and formulation globally in different regulated markets.

The company's consolidated net profit slumped 77.35% to Rs 7.83 crore on 5.44% decrease in revenue from operations to Rs 208.03 crore in Q4 March 2021 over Q4 March 2020.

Powered by Capital Market - Live News

Shilpa Medicare has received an in-principle approval from Defence Research & Development Organisation (DRDO) to manufacture and sale of 2-Deoxy-D-Glucose (2DG).

2DG has been given emergency approval by the Drug Controller General of India (DCGI) for COVID-19 patients in the country. Shilpa Medicare is only the second company in India to have entered into similar arrangement with DRDO.

Shilpa has been continuously striving to contribute towards the fight against COVID-19 and this is yet another step by Shilpa after its recently announced arrangement for manufacture and supply of Sputnik V vaccine.

Powered by Capital Market - Live News